Chimeric antigen receptor engineered cells and their clinical application in infectious disease DOI Creative Commons
Qian Chen, Xiaochen Bo, Jiaqi Hao

и другие.

Clinical and Translational Discovery, Год журнала: 2022, Номер 2(3)

Опубликована: Сен. 1, 2022

Abstract Infectious diseases remain a major burden on global public health and socio‐economic stability. Despite that great progress has been made in the development of drugs, resulting drug resistance remains problem. Patients with no response or recurrence need alternative treatment strategies. The chimeric antigen receptor (CAR) therapy achieves success treating cancer provides new opportunities for infectious diseases. It series advantages targeting, efficacy, durability. In this review, we discussed different CAR strategies diseases, including human immunodeficiency virus, viral hepatitis, cytomegalovirus, severe acute respiratory syndrome coronavirus 2, influenza A virus Aspergillus germlings. Among all these HIV most studied, so mainly reported recent developments preclinical clinical studies anti‐HIV CARs highlighted their structural evolution. current advantages, challenges potential improvements were as well. We also compared CAR‐T cells applied to tumours final part.

Язык: Английский

The Furin Protease Dependence and Antiviral GBP2 Sensitivity of Murine Leukemia Virus Infection Are Determined by the Amino Acid Sequence at the Envelope Glycoprotein Cleavage Site DOI Open Access
Yoshinao Kubo, Manya Bakatumana Hans,

Taisuke Nakamura

и другие.

International Journal of Molecular Sciences, Год журнала: 2024, Номер 25(18), С. 9987 - 9987

Опубликована: Сен. 16, 2024

Host restriction factor GBP2 suppresses the replication of ecotropic Moloney murine leukemia virus (E-MLV) by inhibiting furin protease, which cleaves viral envelope glycoprotein (Env) into surface (SU) and transmembrane (TM) subunits. We analyzed impacts on infection efficiency mediated MLV Envs different strains Moloney, polytropic Friend, amphotropic, xenotropic MLV-related (XMRV) viruses. Interestingly, Friend were sensitive to antiviral activity GBP2, while XMRV amphotropic showed resistance. Consistent with sensitivity amino acid sequences at SU-TM cleavage site similar, as resistant Envs. GBP2-sensitive Env protein was inhibited silencing, whereas that GBP2-resistant not. The substitution sequence conferred resistance both silencing. Reciprocally, According sequence, there variants among ecotropic, polytropic, MLVs. This study found dependence proteins GBP2-mediated is determined site.

Язык: Английский

Процитировано

0

Immune Defenses Against Ranavirus Infections DOI Creative Commons
Leon Grayfer,

Eva‐Stina Edholm,

V. Gregory Chinchar

и другие.

Опубликована: Окт. 11, 2024

Abstract Ranaviruses (RV, family Iridoviridae ) infect fish, amphibians, and reptiles, raising considerable ecological commercial concerns due to the escalating infection prevalence resulting die-offs of wild aquacultural species. Notably, ranaviruses exhibit uncanny capacities cross host species barriers, likely owing their potent immune evasion mechanisms. In turn, infected by these pathogens possess systems that are less well understood than those mammals often encode unique antiviral genes or multiple orthologs single hallmark mammalian factors. Thus, garnering insight into ranavirus strategies is largely contingent on gaining greater understanding barriers faced emerging infectious agents. Accordingly, here we coalesce update current state distinct facets ectothermic vertebrate responses ranaviral infections underline most perspectives which circumvent defenses.

Язык: Английский

Процитировано

0

Modulation of CCR5 expression and R5 HIV-1 infection in primary macrophages exposed to sera from HESN, LTNP, and chronically HIV-1 infected people with or without natural antibodies to CCR5 DOI Creative Commons
Iole Farina, Mauro Andreotti, Claudia Pastori

и другие.

Virus Research, Год журнала: 2024, Номер 350, С. 199506 - 199506

Опубликована: Дек. 1, 2024

CCR5 is the main co-receptor for HIV-1 cell entry and it plays key roles in mucosal transmission. Natural anti-CCR5 antibodies were found HIV-1-exposed seronegative long-term non-progressor subjects, suggesting a role controlling viral replication vivo. We assessed effect of sera containing or not natural antibodies, on membrane level infection primary macrophages. Sera modulated expression with trend dependent donor/serum tested but independent presence absence antibodies. All strongly reduced DNA all donor's macrophages no correlation was observed between levels. These results suggest that major determinant macrophage modulation might depend factors other than CCR5-reactive present and/or intrinsic to donors which tested.

Язык: Английский

Процитировано

0

Zipper interacting protein kinase (ZIPK) is a negative regulator of HIV-1 replication that is restricted by viral Nef protein through proteasomal degradation DOI
Muneesh Kumar Barman,

Kailash Chand,

Debashis Mitra

и другие.

Biochemical and Biophysical Research Communications, Год журнала: 2022, Номер 625, С. 122 - 127

Опубликована: Авг. 3, 2022

Язык: Английский

Процитировано

2

A Truncated Isoform of Cyclin T1 Could Contribute to the Non-Permissive HIV-1 Phenotype of U937 Promonocytic Cells DOI Creative Commons
Tiziana Alberio,

Mariam Shallak,

Amruth Kaleem Basha Shaik

и другие.

Viruses, Год журнала: 2024, Номер 16(8), С. 1176 - 1176

Опубликована: Июль 23, 2024

The different susceptibility to HIV-1 infection in U937 cells-permissive (Plus) or nonpermissive (Minus)-is linked the expression Minus cells of interferon (IFN)-γ inducible antiviral factors such as tripartite motif-containing protein 22 (TRIM22) and class II transactivator (CIITA). CIITA interacts with Cyclin T1, a key component Positive-Transcription Elongation Factor b (P-TEFb) complex needed for efficient transcription upon interaction viral Tat. TRIM22 CIITA, recruiting it into nuclear bodies together T1. A 50 kDa T1 was found only cells, alongside canonical 80 protein. this truncated form remained unaffected by proteasome inhibitors but reduced IFNγ treatment. Unlike full-length protein, also present cytoplasm, subcellular localization correlated its capacity inhibit Tat-mediated transcription. likely contributes their non-permissive phenotype acting dominant negative factor, disrupting P-TEFb formation function. Its reduction treatment suggests regulatory loop which inhibitory role on replication is then exerted IFNγ-induced binds displacing from complex.

Язык: Английский

Процитировано

0

The APOBEC3G gene rs2294367(C>G) variant is associated with HIV-1 infection in Moroccan subjects DOI
Imane Belbacha, Meryem El Azzouzi,

Rajae Bensghir

и другие.

Acta Tropica, Год журнала: 2023, Номер 249, С. 107045 - 107045

Опубликована: Окт. 30, 2023

Язык: Английский

Процитировано

0

Chimeric antigen receptor engineered cells and their clinical application in infectious disease DOI Creative Commons
Qian Chen, Xiaochen Bo, Jiaqi Hao

и другие.

Clinical and Translational Discovery, Год журнала: 2022, Номер 2(3)

Опубликована: Сен. 1, 2022

Abstract Infectious diseases remain a major burden on global public health and socio‐economic stability. Despite that great progress has been made in the development of drugs, resulting drug resistance remains problem. Patients with no response or recurrence need alternative treatment strategies. The chimeric antigen receptor (CAR) therapy achieves success treating cancer provides new opportunities for infectious diseases. It series advantages targeting, efficacy, durability. In this review, we discussed different CAR strategies diseases, including human immunodeficiency virus, viral hepatitis, cytomegalovirus, severe acute respiratory syndrome coronavirus 2, influenza A virus Aspergillus germlings. Among all these HIV most studied, so mainly reported recent developments preclinical clinical studies anti‐HIV CARs highlighted their structural evolution. current advantages, challenges potential improvements were as well. We also compared CAR‐T cells applied to tumours final part.

Язык: Английский

Процитировано

0